申请人:Abou-Gharbia A. Magid
公开号:US20070021488A1
公开(公告)日:2007-01-25
The present invention is directed to compounds of formula I:
where R
1
, R
2
, R
3
, R
4
, and R
5
are as defined herein, and methods of their use for treating certain nervous system disorders and conditions, including, inter alia, vasomotor symptoms (VMS) and chronic pain.
本发明涉及I式化合物:其中R1、R2、R3、R4和R5如本文所定义,并且它们的使用方法用于治疗某些神经系统疾病和病况,包括但不限于血管运动症状(VMS)和慢性疼痛。